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In the united states, nearly 60,000 patients per day receive general anesthesia for surgery.1
General anesthesia is a drug-induced, reversible condition that includes specific behavioral
and physiological traits — unconsciousness, amnesia, analgesia, and akinesia — with
concomitant stability of the autonomic, cardiovascular, respiratory, and thermoregulatory
systems.2 General anesthesia produces distinct patterns on the electroencephalogram (EEG),
the most common of which is a progressive increase in low-frequency, high-amplitude
activity as the level of general anesthesia deepens3,4 (Fig. 1). How anesthetic drugs induce
and maintain the behavioral states of general anesthesia is an important question in medicine
and neuroscience.6 Substantial insights can be gained by considering the relationship of
general anesthesia to sleep and to coma.
Humans spend approximately one third of their lives asleep. Sleep, a state of decreased
arousal that is actively generated by nuclei in the hypothalamus, brain stem, and basal
forebrain, is crucial for the maintenance of health.7,8 Normal human sleep cycles between
two states — rapid-eye-movement (REM) sleep and non-REM sleep — at approximately
90-minute intervals. REM sleep is characterized by rapid eye movements, dreaming,
irregularities of respiration and heart rate, penile and clitoral erection, and airway and
skeletal-muscle hypotonia.7 In REM sleep, the EEG shows active high-frequency, low-
amplitude rhythms (Fig. 1). Non-REM sleep has three distinct EEG stages, with higher-
amplitude, lower-frequency rhythms accompanied by waxing and waning muscle tone,
decreased body temperature, and decreased heart rate.
Coma is a state of profound unresponsiveness, usually the result of a severe brain injury.9
Comatose patients typically lie with eyes closed and cannot be roused to respond
appropriately to vigorous stimulation. A comatose patient may grimace, move limbs, and
have stereotypical withdrawal responses to painful stimuli yet make no localizing responses
or discrete defensive movements. As the coma deepens, the patient’s responsiveness even to
painful stimuli may diminish or disappear. Although the patterns of EEG activity observed
in comatose patients depend on the extent of the brain injury, they frequently resemble the
high–amplitude, low-frequency activity seen in patients under general anesthesia10 (Fig. 1).
General anesthesia is, in fact, a reversible drug-induced coma. Nevertheless,
anesthesiologists refer to it as “sleep” to avoid disquieting patients. Unfortunately,
anesthesiologists also use the word “sleep” in technical descriptions to refer to
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unconsciousness induced by anesthetic drugs.11 (For a glossary of terms commonly used in
the field of anesthesiology, see the Supplementary Appendix, available with the full text of
this article at NEJM.org.)
This review discusses the clinical and neurophysiological features of general anesthesia and
their relationships to sleep and coma, focusing on the neural mechanisms of
unconsciousness induced by selected intravenous anesthetic drugs.
CLINICAL SIGNS AND EEG PAT TERNS OF UNCONSCIOUSNESS INDUCED
BY GENER AL ANESTHESIA
The clinical signs and EEG patterns of general anesthesia–induced unconsciousness can be
described in relation to the three periods in which they appear: induction, maintenance, and
emergence.
INDUCTION PERIOD
Before induction, the patient has a normal, active EEG, with prominent alpha activity (10
Hz) when the eyes are closed (Fig. 1). Administration of a small dose of a hypnotic drug
such as propofol, a barbiturate, or etomidate, all of which act on γ-aminobutyric acid type A
(GABAA) receptors, induces a state of sedation in which the patient is calm and easily
arousable, with the eyes generally closed.12 As the dose is slowly increased, the patient may
enter a state of paradoxical excitation,13 characterized by purposeless or defensive
movements, incoherent speech, euphoria or dysphoria, and an increase in beta activity on the
EEG (13 to 25 Hz).3,4,13–16 This state is termed paradoxical because the drug that is
intended to induce unconsciousness induces excitation instead.
As more of the hypnotic agent is administered — typically as a bolus over a period of 10 to
15 seconds — an increasingly irregular respiratory pattern develops that progresses to apnea,
at which point bag-mask ventilation must be initiated to support breathing. There is a
concomitant loss of response to oral commands and skeletal-muscle tone. Loss of
consciousness can be easily assessed by having patients follow the movement of the
anesthesiologist’s finger with their eyes. As unconsciousness ensues, eye tracking stops,
nystagmus may appear, and blinking increases. The oculocephalic, eyelash, and corneal
reflexes are lost,17 yet the pupillary light reflex remains.18 There can be either an increase or
a decrease in blood pressure, whereas the heart rate typically increases. Administering an
opioid or a benzodiazepine before or during induction may mitigate the increased heart-rate
response, and vaso-pressors may be given to maintain blood pressure. Tracheal intubation is
usually performed at the end of induction, after the administration of a muscle relaxant.
MAINTENANCE PERIOD
General anesthesia is maintained by a combination of hypnotic agents, inhalational agents,
opioids, muscle relaxants, sedatives, and cardiovascular drugs, along with ventilatory and
thermoregulatory support. During the maintenance period, changes in the heart rate and
blood pressure are among the clinical signs used to monitor the level of general anesthesia
(see the Supplementary Appendix). When the state of general anesthesia is inadequate for
the level of nociceptive stimulation from surgery, the heart rate and blood pressure can
increase dramatically, alerting the anesthesiologist to the possibility of increased nociception
and arousal. Other indicators of inadequate general anesthesia are perspiration, tearing,
changes in pupil size, the return of muscle tone, movement,19 and changes in EEG measures
of brain activity.20 At levels appropriate for surgery, general anesthesia can functionally
approximate brain-stem death,21 because patients are unconscious, have depressed brain-
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stem reflexes, do not respond to nociceptive stimuli, have no apneic drive, and require
cardiorespiratory and thermoregulatory support.9
Four EEG patterns define the phases of the maintenance period (Fig. 1). Phase 1, a light
state of general anesthesia, is characterized by a decrease in EEG beta activity (13 to 30 Hz)
and an increase in EEG alpha activity (8 to 12 Hz) and delta activity (0 to 4 Hz).22 During
phase 2, the intermediate state, beta activity decreases and alpha and delta activity increases,
with so-called anteriorization — that is, an increase in alpha and delta activity in the anterior
EEG leads relative to the posterior leads.22,23 The EEG in phase 2 resembles that seen in
stage 3, non-REM (or slow-wave) sleep. Phase 3 is a deeper state, in which the EEG is
characterized by flat periods interspersed with periods of alpha and beta activity — a pattern
called burst suppression.15 As this state of general anesthesia deepens, the time between the
periods of alpha activity lengthens, and the amplitudes of the alpha and beta activity
decrease. Surgery is usually performed during phases 2 and 3. In phase 4, the most profound
state of general anesthesia, the EEG is isoelectric (completely flat). An isoelectric EEG may
be purposely induced by the administration of a barbiturate or propofol to protect the brain
during neurosurgery24 or to stop generalized seizures.25,26
EMERGENCE PERIOD
Emergence from general anesthesia is a passive process that depends on the amounts of
drugs administered; their sites of action, potency, and pharmacokinetics; the patient’s
physiological characteristics; and the type and duration of the surgery. Recovery from
general anesthesia is generally assessed by monitoring physiological and behavioral signs.
The return of spontaneous respirations is typically one of the first clinical signs observed
once peripheral neuromuscular blockade is decreased. This marks the patient’s return from a
functional state that approximates brainstem death (Table 1). The heart rate and blood
pressure typically increase, provided that these responses are not pharmacologically
blocked. Salivation and tearing begin, followed by nonlocalizing responses to painful
stimulation, suggesting that the patient’s state is most similar to a vegetative state with the
notable exception that the eyes remain closed. As skeletal-muscle tone returns, the patient
begins to grimace, swallow, gag, and cough and make defensive movements, such as
reaching for the endotracheal or naso-gastric tube. At this point the anesthesiologist will
perform extubation, provided that there is sufficient return of brain-stem reflexes to maintain
spontaneous respirations and airway protection, even if there is no response to oral
commands. The eyes may still not open spontaneously. As the patient emerges from general
anesthesia, the EEG patterns proceed in approximately reverse order from phases 2 or 3 of
the maintenance period to an active EEG that is consistent with a fully awake state (Fig. 1).
Between extubation and discharge from the postanesthesia care unit, the patient passes
through a minimally conscious state.27 Functional responses that are beyond a minimally
conscious state must be evident before the patient is discharged from the postanesthesia care
unit.27,28 The patient should be able to answer simple questions and to convey any
discomfort, such as pain or nausea.
MECHANISMS OF UNCONSCIOUSNESS INDUCED BY GENER AL
ANESTHESIA
CORTICAL CIRCUITS AND ALTERED AROUSAL
Observations from clinical practice and basic science indicate that anesthetic drugs induce
unconsciousness by altering neurotransmission at multiple sites in the cerebral cortex,29–35
brain stem, and thalamus. If a procedure does not require full general anesthesia, it is
standard clinical practice to use low doses of a hypnotic or sedative drug to achieve
sedation, which is defined as diminished cognitive function (cortical activity)35 with intact
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respiratory and cardiovascular (brain-stem) function. Substantial decreases in neural activity
in the cortex have been observed in a rodent model of general anesthesia.30 Similarly,
positron-emission tomographic studies in humans under general anesthesia revealed
appreciable decreases in cortical metabolic activity.31,32 Functional magnetic resonance
imaging33 and local-field-potential recordings34 in humans have provided additional
evidence of cortical mechanisms of unconsciousness induced by general anesthesia. In vivo
and in vitro molecular pharmacologic studies have identified GABAA and N-methyl-D-
aspartate (NMDA) receptors in the cortex, thalamus, brain stem, and striatum as two of the
important targets of hypnotic drugs.36,37 Because small numbers of inhibitory interneurons
control large numbers of excitatory pyramidal neurons, the enhanced GABAA inhibition
induced by general anesthesia can efficiently inactivate large regions of the brain and
contribute to unconsciousness (Fig. 2A).38,39
THE BRAIN STEM, SLEEP, AND ALTERED AROUSAL
A hypnotic drug administered as a bolus during induction of general anesthesia rapidly
reaches brain-stem arousal centers, where it contributes to unconsciousness.40 The clinical
signs cited above are consistent with actions in the brain stem. Losses of the oculocephalic
and corneal reflexes are nonspecific indicators of impaired brain-stem function due to the
actions of the hypnotic agent on the oculomotor, trochlear, abducens, trigeminal, and facial
nuclei in the midbrain and pons.9
In a study in rodents, direct injection of a barbiturate into the mesopontine tegmental area
led to unconsciousness.41 Such observations confirm brain-injury studies showing that
brain-stem unconsciousness typically involves the lateral dorsal tegmental areas of the pons
and the midbrain paramedian region.42 Apnea can be explained, in part, by the actions of the
hypnotic agent on GABAA interneurons in the respiratory control network in the ventral
medulla and pons.43
The rapid atonia that occurs after bolus administration of propofol is most likely due to the
actions of this drug in the spinal cord44 and in the pontine and medullary reticular nuclei that
control the antigravity muscles.45 Certain observations are consistent with this concept of
propofol’s mechanism of action — for example, the atonia that follows the inadvertent
injection of local anesthetics into the subarachnoid space or basilar artery during an
interscalene block46,47 or the inadvertent injection of alcohol into the cervical spinal cord
during a facet block.9 Furthermore, observations in patients who have pontine strokes and
locked-in syndromes support this concept,9 as do observations with the muscle-relaxing and
soporific effects of the GABA agonist baclofen.48 Such observations may explain why near
the end of surgery, small doses of propofol can be used to provide rapid muscle relaxation of
short duration and why, in this case, propofol is preferable to muscle relaxants that have a
slower onset and longer duration of action. In contrast to the drug-induced atonia described
above, rigidity and spasticity are typically seen in patients who are in a coma or a vegetative
state,9 and muscle tone is preserved during slow-wave sleep.7
Signs of the loss of brain-stem function (apnea, atonia, and losses of the oculocephalic and
corneal49 reflexes) and hence unconsciousness reliably indicate when to initiate bag-mask
ventilation or to place a laryngeal mask airway during induction of general anesthesia.
Neural circuits involved in sleep provide additional insights into basal forebrain, brain-stem,
and hypothalamic mechanisms of unconsciousness. During the awake state, the locus
ceruleus provides norepinephrine-mediated inhibition of the ventrolateral preoptic nucleus in
the hypothalamus.50,51 Therefore, GABAA-mediated and galanin-mediated inhibition of the
ascending arousal circuits by the ventrolateral preoptic nucleus is inhibited and the awake
state is promoted.51 Adenosine, one of the brain’s principal somnogens, accumulates from
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degradation of adenosine triphosphate during prolonged intervals of wakefulness.8 Binding
of adenosine in the ventrolateral preoptic nucleus is associated with increased activity in this
brain center.52 Adenosine binding and inhibition of the locus ceruleus lead to activation of
the ventrolateral preoptic nucleus, which inhibits the ascending arousal circuits and
promotes non-REM sleep. The sedative dexmedetomidine is an α2-adrenergic agonist that
inhibits the release of norepinephrine from the locus ceruleus and thus allows the
ventrolateral preoptic nucleus to reduce arousal by inhibiting the ascending arousal circuits
(Fig. 2B).53,54 The EEG patterns of dexmedetomidine-induced sedation closely resemble
those of non-REM sleep.55 Propofol also promotes unconsciousness, in part, by GABAA-
mediated inhibition of release of the arousal-promoting neurotransmitter histamine in the
cortex from the tuberomammillary nucleus in the hypothalamus.50
The active EEG patterns observed during REM sleep are due in part to strong cholinergic
inputs from the lateral dorsal tegmental and pedunculopontine tegmental nuclei to the
medial pontine reticular formation and thalamus and from the basal forebrain to the cortex.56
The synthetic opioid fentanyl decreases arousal by reducing acetylcholine in the medial
pontine reticular formation, whereas morphine decreases arousal by inhibiting the neurons in
the lateral dorsal teg-mental nucleus, medial pontine reticular formation,56 and basal
forebrain57 (Fig. 2C). Opioids further contribute to unconsciousness by binding to opioid
receptors in the periaqueductal gray,58 rostral ventral medulla,58,59 spinal cord,59 and
possibly peripheral tissue60 to reduce nociceptive transmission in the central nervous
system. That opioids act primarily in the nociceptive pathways rather than in the cortex to
alter arousal and to partially alter cognition helps explain the high incidence of postoperative
awareness in patients undergoing cardiac surgery, for which high-dose opioids have, until
recently, been the primary anesthetic.61,62
Clinical studies have shown that unconsciousness induced by propofol can be reversed by
the administration of the cholinomimetic agent physostigmine.63 A combination of
imaging,31 molecular,37 and neurophysiological30 studies suggests that propofol acts, in
part, by enhancing GABAA-mediated inhibition by interneurons of pyramidal neurons in the
cortex and subcortical areas,50 whereas physostigmine counteracts this effect by enhancing
cholinergic activity throughout the cortex (Fig. 2A). Physostigmine is a standard treatment
for emergence delirium,64,65 a state of confusion seen on emergence from general
anesthesia.
The EEG patterns and other features of general anesthesia generally differ from those of
sleep (Fig. 1). The highly active state of the cortex during REM sleep is mediated by a
cholinergic drive emanating from the basal forebrain and from the lateral dorsal and
pedunculopontine tegmental nuclei to the cortex via the thalamus.56 As discussed below,
paradoxical excitation under general anesthesia may represent GABA-mediated
disinhibition in striatothalamic pathways. The skeletal-muscle hypotonia observed during
REM sleep is partially due to cholinergic activation of pontomedullary networks, resulting
in glycine-mediated inhibition of alpha motor neurons in the spinal cord,66 whereas during
paradoxical excitation, motor tone is preserved.13
There is similarity between the EEG patterns seen in slow-wave sleep and those seen in
phase 2 of the maintenance period of general anesthesia (Fig. 1). This period of general
anesthesia is sufficiently deep to perform surgery. During sleep, the greatest decrease in pain
perception occurs in the slow-wave stage. Arousal is possible during this stage, but it
requires stronger stimulation than during other stages of sleep.67 Slow-wave sleep has been
shown to represent the switch of the thalamus from its tonic to its bursting mode.68 The
tonic mode favors transmission of somato-sensory information through the thalamus,
whereas the bursting mode inhibits transmission of such information. Phase 2 of the
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maintenance period of general anesthesia and slow-wave sleep represent profound decreases
in cortical activity achieved by pharmacologic means and by an endogenous circuit
mechanism, respectively.
CENTRAL THALAMIC CIRCUITS AND CONTROL OF AROUSAL
The central thalamus plays an important role in normal arousal regulation.69 The
convergence in this area of ascending pathways from the brain stem and basal forebrain and
descending pathways from the frontal cortex helps regulate forebrain arousal and maintain
organized behavior during wakefulness. Both direct injury of the central thalamus and
marked deafferentation of its neurons due to diffuse brain insults are associated with the
severe impairment of arousal and of forebrain functional integration observed in several
brain disorders.70 Electrical stimulation of the central thalamus in a minimally conscious
patient has been reported to improve cognitive function, mobility, and oral feeding.71
Similarly, unconsciousness induced by general anesthesia has been reversed experimentally
by the direct injection of cholinergic agonists into the central thalamus.72
The central thalamus may mediate several of the phenomena seen in general anesthesia, as
described above (Fig. 3). A possible explanation for the paradoxical excitation observed
with a low dose of nearly every anesthetic drug3,4,13–16 is suggested by the circuit
mechanism,69,73 which has been proposed to explain the paradoxical arousal of a patient
from a minimally conscious state after administration of the GABAA1 agonist zolpidem.74
After administration of zolpidem, the marked downregulation of the anterior-forebrain
network that accompanied this patient’s brain injury was reversed, with notable functional
improvement. The globus pallidus interna normally provides tonic inhibitory inputs to the
central thalamus that are opposed by striatal inhibition of the pallidum. Binding of zolpidem
in the GABAA1-receptor–rich globus pallidus interna may suppress this tonic inhibitory
input to the thalamus,75 fostering activation of thalamocortical and thalamostriatal circuits
and, consequently, enhancing arousal (Fig. 3A). For anesthetic drugs that promote GABAA
inhibition, paradoxical excitation may be explained by a similar action in these circuits. This
hypothesis could also account for the paradoxical excitation observed during endoscopy and
the delirium observed in intensive care units that is commonly associated with sedation
induced with benzodiazepines, which are GABAA agonists.76,77 The fact that purpose-less
movements are associated with paradoxical excitation is consistent with a possible basal
ganglia mechanism.13
An imaging study in humans suggests a role for the corticobasal ganglia–thalamic circuit in
propofol-induced unconsciousness.78 This circuit may also underlie anteriorization (Fig.
3B). The delta and alpha rhythms seen on the EEG during general anesthesia and sleep79
could arise from sustained hyperpolarization of pyramidal neurons in the lower output layers
of the cortex owing to withdrawal (during sleep) or inhibition (during general anesthesia) of
excitatory synaptic inputs.80 Initiation of these changes in the anterior forebrain could be a
consequence of active inhibition of the central thalamus that occurs when cortical inputs to
the striatum are insufficient (Fig. 3A). A theoretical model has shown that as propofol is
increased to a dose beyond that which produces paradoxical excitation, its actions in the
thalamocortical circuits lead to a coherent alpha oscillation between the thalamus and the
anterior forebrain.81
Finally, burst suppression is believed to be a strong, synchronized outflow of thalamic
discharges to a widely unresponsive cortex82 (Fig. 1). It is a deeper state of general
anesthesia than is phase 2 of the maintenance period, which resembles the tonic bursting
mode of the thalamus seen in slow-wave sleep. Bursts become more widely separated during
burst suppression as the level of general anesthesia deepens. This suggests that a larger
fraction of the cortex is inactive during burst suppression relative to phase 2 of general
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anesthesia or slow-wave sleep. Supporting this hypothesis is the observation that burst
suppression is also seen in coma due to diffuse anoxic damage,83 induced hypothermia,84
and epilepsy due to the Ohtahara syndrome.85 The absence of burst suppression during sleep
is an important electrophysiological distinction between sleep and general anesthesia.
ACTIVE BR AIN STATES AND UNCONSCIOUSNESS
In contrast to unconsciousness induced by most hypnotic agents, which is predominantly
associated with slow EEG patterns, unconsciousness induced by the NMDA antagonist
ketamine is associated with active EEG patterns.86,87 Seizures are commonly associated
with active, highly organized EEG patterns. Unconsciousness due to seizures most likely
results from organized, aberrant brain activity that impedes the normal communications
necessary to maintain arousal and cognition.88 Similarly, a highly active brain state most
likely plays a role in unconsciousness induced by ketamine. Ketamine preferentially inhibits
NMDA-mediated glutamatergic inputs to GABAergic interneurons, leading to aberrant
excitatory activity in the cortex, hippocampus, and limbic system and ultimately
unconsciousness (Fig. 4).89,90 Hallucinations may result because the aberrant activation
allows the association of information in a manner that is inconsistent in time and space. The
hallucinations can be mitigated by the concurrent administration of a benzodiazepine,91
which presumably acts to enhance GABAA-mediated activity of the interneurons and hence
leads to sedation. The potent antinociceptive effects of ketamine on NMDA receptors in the
spinal cord and its inhibition of acetylcholine release from the pons also contribute to
unconsciousness (Fig. 4).92–94
EMERGENCE FROM GENER AL ANESTHESIA AND RECOVERY FROM
COMA
Recovery from an initial coma — if it occurs — may require hours to years. In contrast,
emergence from general anesthesia typically requires minutes. Nevertheless, it is useful to
compare emergence from general anesthesia and recovery from coma (Table 1). The early
clinical signs of emergence from general anesthesia — return of regular breathing,
salivation, tearing, swallowing, gagging, and grimacing — approximate the caudal–rostral
progression in the brain stem of the return of sensory, motor, and autonomic function (Table
1). A later sign, such as response to oral commands, indicates the return of cortical function.
The quantitative neurobehavioral metrics used to monitor recovery from coma could be used
to track the emergence from general anesthesia from a functional state that can approximate
brain-stem death to states similar to a vegetative state and, eventually, to a minimally
conscious state.95 The fact that general anesthesia can be functionally equivalent to brain-
stem death indicates how deeply general anesthesia can depress brain function and perhaps
explains why some patients do not fully recover consciousness for several hours after
general anesthesia and why postoperative cognitive dysfunction could persist in elderly
patients for several months.96
In conclusion, a better understanding of sleep and coma may lead to new approaches to
general anesthesia based on new ways to alter consciousness,29,97,98 provide analgesia,99,100
induce amnesia, and provide muscle relaxation.66
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Figure 1. Electroencephalographic (EEG) Patterns during the Awake State, General Anesthesia,
and Sleep
Panel A shows the EEG patterns when the patient is awake, with eyes open (left) and the
alpha rhythm (10 Hz) with eyes closed (right). Panel B shows the EEG patterns during the
states of general anesthesia: paradoxical excitation, phases 1 and 2, burst suppression, and
the isoelectric tracing. Panel C shows the EEG patterns during the stages of sleep: rapid-eye-
movement (REM) sleep; stage 1 non-REM sleep; stage 2 non-REM sleep, and stage 3 non-
REM (slow-wave) sleep. The EEG patterns during recovery from coma — coma, vegetative
state, and minimally conscious state — resemble the patterns during general anesthesia,
sleep, and the awake state. EEG tracings during sleep are from Watson et al.5
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Figure 2. Possible Neural-Circuit Mechanisms of Altered Arousal Induced by Anesthetic Agents
Panel A shows a GABAergic inhibitory interneuron (orange) synapsing on a pyramidal
neuron (gray) receiving excitatory inputs from ascending arousal pathways. The
monoaminergic pathways arise from the locus ceruleus, which releases norepinephrine; the
raphe, which releases serotonin; the tuberomammillary nucleus, which releases histamine;
and the ventral teg-mental area, which releases dopamine. The cholinergic pathways, which
release acetylcholine, arise from the basal forebrain, the lateral dorsal tegmental nuclei, and
the pedunculopontine tegmental nuclei. Lateral hypothalamic neurons release orexin.
Propofol binds post-synaptically and enhances GABAergic inhibition, counteracting arousal
inputs to the pyramidal neuron, decreasing its excitatory activity, and contributing to
unconsciousness. Dexmedetomidine binds to α2 receptors on neurons from the locus
ceruleus, inhibiting norepinephrine release (dashed line) in the ventrolateral preoptic
nucleus, as shown in Panel B. The disinhibited ventrolateral preoptic nucleus reduces
arousal by means of GABAA-mediated and galanin-mediated inhibition of the midbrain,
hypothalamic, and pontine arousal nuclei. As shown in Panel C, opioids reduce arousal by
inhibiting the release of acetylcholine from neurons projecting from the lateral dorsal and
pedunculopontine tegmental nuclei to the medial pontine reticular formation and to the
thalamus, by binding to opioid receptors in the periaqueductal gray and rostral ventral
medulla, and by binding presynaptically and postsynaptically to spinal cord opioid receptors
at the synapses between peripheral afferent neurons in the dorsal-root ganglion and
projecting neurons.
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Figure 3. Paradoxical Excitation, Cerebral Metabolism, and Electroencephalographic (EEG)
Activity in Stages of Coma Recovery
Cortical damage causes loss of excitatory inputs from the frontal cortex to the median spiny
neurons in the striatum, as shown in Panel A. Normal striatal inhibition of the globus
pallidus interna is lost, and the globus pallidus interna tonically inhibits the thalamus.
Zolpidem and propofol may bind to GABAA1 receptors in the globus pallidus interna,
blocking its inhibitory inputs to the thalamus; as a result, excitatory cortical inputs from the
thalamus are restored, causing paradoxical excitation.73 Panel B schematically depicts
changes in cerebral metabolism as measured by positron emission tomographic (PET)
scanning and on electroencephalography (EEG) at different stages of coma recovery. In the
awake state, the EEG pattern is active and cerebral metabolism is globally active.
Paradoxical excitation induced by the administration of zolpidem, which is associated with
behavioral improvement in some minimally conscious patients, is reflected by an active
EEG pattern with reduced prefrontal cortex metabolism. Patients in minimally conscious
and vegetative states may show EEG anteriorization, with alpha, theta, and delta EEG
patterns and decreased metabolism in the frontal cortex, striatum, and thalamus. Burst
suppression in coma correlates with globally depressed metabolism. General anesthesia
results in similar EEG patterns. A denotes anterior, and P posterior.
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Figure 4. Unconsciousness and Active Brain States
Ketamine binds preferentially to N-methyl-D-aspartate (NMDA) receptors on inhibitory
interneurons in the cortex, limbic system (amygdala), and hippocampus, promoting an
uncoordinated increase in neural activity, an active electroencephalographic pattern, and
unconsciousness, as shown in Panel A. In the spinal cord, ketamine decreases arousal by
blocking NMDA glutamate (Glu)–mediated nociceptive signals from peripheral afferent
neurons in the dorsal-root ganglion to projecting neurons, as shown in Panel B.
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Table 1
Emergence from General Anesthesia and Stages of Recovery from Coma.*
Emergence from General Anesthesia Recovery from Coma
General anesthesia
Stable administration of anesthetic drugs
Arousal not possible, unresponsive; eyes closed, with reactive pupils
Analgesia, akinesia
Drug-controlled blood pressure and heart rate
Mechanically controlled ventilation
EEG patterns ranging from delta and alpha activity to burst suppression
Brain-stem death
No respiratory response to apneic oxygenation test
Total loss of brain-stem reflexes
Isoelectric EEG pattern
Coma
Structural brain damage to both cerebral hemispheres, with or
without injuries to tegmental midbrain, rostral pons, or both
Isolated bilateral injuries to midline tegmental midbrain, rostral
pons, or both
Arousal not possible, unresponsive
Functionally intact brain stem, normal arterial blood gases
EEG pattern of low-amplitude delta activity and intermittent
bursts of theta and alpha activity or possibly burst suppression
Emergence, phase 1
Cessation of anesthetic drugs
Reversal of peripheral-muscle relaxation (akinesis)
Transition from apnea to irregular breathing to regular breathing
Increased alpha and beta activity on EEG
Vegetative state
Spontaneous cycling of eye opening and closing
Grimacing and nonpurposeful movements
EEG pattern of high-amplitude delta and theta activity
Absence of EEG features of sleep
Usually able to ventilate without mechanical support
Emergence, phase 2
Increased heart rate and blood pressure
Return of autonomic responsiveness
Responsiveness to painful stimulation
Salivation (7th and 9th cranial nerve nuclei)
Tearing (7th cranial nerve nuclei)
Grimacing (5th and 7th cranial nerve nuclei)
Swallowing, gagging, coughing (9th and 10th cranial nerve nuclei)
Return of muscle tone (spinal cord, reticulospinal tract, basal ganglia, and
primary motor tracts)
Defensive posturing
Further increase in alpha and beta activity on EEG
Extubation possible
Emergence, phase 3
Eye opening
Responses to some oral commands
Awake patterns on EEG
Extubation possible
Minimally conscious state
Purposeful guarding movements, eye tracking
Inconsistent communication, verbalizations
Following oral commands
Return of sleep–wake cycles
Recovery of some EEG features of normal sleep–wake
architecture
*
EEG denotes electroencephalogram.
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